W
Wanjun Yan
Researcher at Xi'an Jiaotong University
Publications - 9
Citations - 316
Wanjun Yan is an academic researcher from Xi'an Jiaotong University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 8, co-authored 8 publications receiving 197 citations.
Papers
More filters
Journal ArticleDOI
Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K/AKT pathway in vivo and vitro.
TL;DR: It is demonstrated that baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting the PI3K/AKT signaling pathway in vivo and vitro and in vivo.
Journal ArticleDOI
Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway
TL;DR: It is demonstrated that baicalein has the potential to suppress breast cancer metastasis, possibly by inhibition of EMT, which may be attributed to downregulation of both SATB1 and the Wnt/β-catenin pathway.
Journal Article
Baicalein suppress EMT of breast cancer by mediating tumor-associated macrophages polarization.
Xixi Zhao,Jingkun Qu,Xu Liu,Jizhao Wang,Xingcong Ma,Xiaoyao Zhao,Qian Yang,Wanjun Yan,Zitong Zhao,Yuxin Hui,Haocheng Bai,Shuqun Zhang +11 more
TL;DR: The findings suggest that the regulation of TAMs may be a novel mechanism underlying the anti-tumor effects of baicalein in breast cancer.
Journal ArticleDOI
Association between three functional microRNA polymorphisms (miR-499 rs3746444, miR-196a rs11614913 and miR-146a rs2910164) and breast cancer risk: a meta-analysis.
TL;DR: It is demonstrated that rs3746444 could increase breast cancer risk in Asians and in general populations, while rs11614913 could decrease the risk of breast cancer in Caucasians.
Journal ArticleDOI
Association of miR-196a2 rs11614913 and miR-499 rs3746444 polymorphisms with cancer risk: a meta-analysis.
TL;DR: A meta-analysis suggests that the miR-196a2 rs11614913 most likely contributes to decreased susceptibility to cancer, especially in Asians and colorectal cancer and gastric cancer, and that the rs3746444 may increase risk for cancer.